Cumulative Effects of Psychologic Distress, Visceral Hypersensitivity, and Abnormal Transit on Patient-reported Outcomes in Irritable Bowel Syndrome

Irritable Bowel Syndrome (IBS) and Chronic Constipation

Effect of Antidepressants and Psychological Therapies in Irritable Bowel Syndrome: An Updated Systematic Review and Meta-analysis

Am J Gastroenterol.

Ford AC, Lacy BE, Harris LA, Quigley EM, Moayyedi P

doi: 10.1038/s41395-018-0222-5.

Irritable Bowel Syndrome (IBS) and Chronic Constipation

A microbial signature of psychological distress in irritable bowel syndrome

Psychosom Med.

Peter J, Fournier C, Durdevic M, Knoblich L, Keip B, Dejaco C, Trauner M, Moser G

doi: 10.1097/PSY.

Irritable Bowel Syndrome (IBS) and Chronic Constipation

Functional Dyspepsia and Severity of Psychologic Symptoms Associate With Postprandial Symptoms in Patients With Irritable Bowel Syndrome

Clin Gastroenterol Hepatol.

Pohl D, Van Oudenhove L, Törnblom H, Le Nevé B, Tack J, Simrén M

doi: 10.1016/j.cgh.2018.04.034.

Irritable Bowel Syndrome (IBS) and Chronic Constipation

Irritable Bowel Syndrome (IBS) and Chronic Constipation Long-term treatment with plecanatide was safe and tolerable in patients with irritable bowel syndrome with constipation

Curr Med Res Opin.

Barish CF, Crozier RA, Griffin P

doi: 10.1080/03007995.

Irritable Bowel Syndrome (IBS) and Chronic Constipation

Cumulative Effect of Psychological Alterations on Gastrointestinal Symptom Severity in Irritable Bowel Syndrome

Am J Gastroenterol

Midenfjord I, Borg A, Törnblom H, Simrén M

doi: 10.14309/ajg.0000000000001038

Irritable Bowel Syndrome (IBS) and Chronic Constipation

New Protocol for Production of Reduced-Gluten Wheat Bread and Pasta and Clinical Effect in Patients with Irritable Bowel Syndrome: A randomised, Double-Blind, Cross-Over Study

doi: 10.3390/nu10121873.

Irritable Bowel Syndrome (IBS) and Chronic Constipation

Effects of Psychology and Extra-Gastrointestinal Symptoms on Healthcare Use by Subjects With and Without Irritable Bowel Syndrome

Clin Gastroenterol Hepatol.

McNaughton DT, Andreasson A, Ljótsson B, Beath AP, Hush JM, Talley NJ, Ljunggren G, Schmidt PT, Agréus L, Jones MP

doi: 10.1016/j.cgh.2019.07.019.

Irritable Bowel Syndrome (IBS) and Chronic Constipation

Efficacy and Safety of Eluxadoline in Patients With Irritable Bowel Syndrome With Diarrhea Who Report Inadequate Symptom Control With Loperamide: RELIEF Phase 4 Study

Am J Gastroenterol.

Brenner DM, Sayuk GS, Gutman CR, Jo E, Elmes SJR, Liu LWC, Cash BD

doi: 10.14309/ajg.0000000000000327.

Inflammatory Bowel Disease

Comparison of the metabolomic profiles of irritable bowel syndrome patients with ulcerative colitis patients and healthy controls: new insights into pathophysiology and potential biomarkers

Aliment Pharmacol Ther.

Keshteli AH, Madsen KL, Mandal R, Boeckxstaens GE, Bercik P, De Palma G, Reed DE, Wishart D, Vanner S, Dieleman LA

doi: 10.1111/apt.15141.

Related content

Effect of Antidepressants and Psychological Therapies in Irritable Bowel Syndrome: An Updated Systematic Review and Meta-analysis

A microbial signature of psychological distress in irritable bowel syndrome

Functional Dyspepsia and Severity of Psychologic Symptoms Associate With Postprandial Symptoms in Patients With Irritable Bowel Syndrome

Irritable Bowel Syndrome (IBS) and Chronic Constipation Long-term treatment with plecanatide was safe and tolerable in patients with irritable bowel syndrome with constipation

Cumulative Effect of Psychological Alterations on Gastrointestinal Symptom Severity in Irritable Bowel Syndrome

New Protocol for Production of Reduced-Gluten Wheat Bread and Pasta and Clinical Effect in Patients with Irritable Bowel Syndrome: A randomised, Double-Blind, Cross-Over Study

Effects of Psychology and Extra-Gastrointestinal Symptoms on Healthcare Use by Subjects With and Without Irritable Bowel Syndrome

Efficacy and Safety of Eluxadoline in Patients With Irritable Bowel Syndrome With Diarrhea Who Report Inadequate Symptom Control With Loperamide: RELIEF Phase 4 Study

Comparison of the metabolomic profiles of irritable bowel syndrome patients with ulcerative colitis patients and healthy controls: new insights into pathophysiology and potential biomarkers